Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Eur J Neurosci. 2009 Jul 7;30(2):242–250. doi: 10.1111/j.1460-9568.2009.06812.x

Figure 2. Mean arterial blood pressure and baseline blood flow level across variable doses of isoflurane.

Figure 2

A: Subject-to-subject comparison of MABP between low and high doses (N = 12). Note that the systemic blood pressure significantly decreased under high-dose conditions (2.1% Iso). *P < 0.05. B: Subject-to-subject comparison of the mean baseline LDF (N = 12). The baseline LDF level is presented as the raw LDF output value (a.u.). No significant differences between low and high doses were observed.